Silence Therapeutics Appoints Max Herrmann As Chief Financial Officer
LONDON, April 15, 2010 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) (Silence or the Company) announces the appointment of Max Herrmann as the Company's chief financial officer and company…